由于性发作导致的重复性跌倒的恶化,其次是佩拉曼奈尔的使用
Akiko Maeda1, Shuichiro Neshige2, Riho Katsumata1
1Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Hiroshima, JPN.
矛盾的是,佩拉曼奈尔 (PER) 可以使列诺克斯-加斯托综合征患者的发作恶化,导致受伤. 停止PER治疗改善了心肌,这表明这种AMPA受体对抗剂的潜在不良影响.
科学领域:
- 神经学 神经学
- 临床药理学 临床药理学
背景情况:
- 伦诺克斯-加斯托综合征 (LGS) 是一种严重的,其特征是频繁,多种类型的发作.
- 珀兰 (PER) 是一种抗药物,向AMPA受体,作为的补充疗法.
更多相关视频
06:58Non-restraining EEG Radiotelemetry: Epidural and Deep Intracerebral Stereotaxic EEG Electrode Placement
Published on: June 25, 2016
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Desensitization and Tachyphylaxis
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
